共 50 条
- [1] Phase 1b/2 keynote-365 trial: Pembrolizumab (pembro) combination therapy in metastatic castration-resistant prostate cancer (mCRPC).JOURNAL OF CLINICAL ONCOLOGY, 2017, 35Yu, Evan Y.论文数: 0 引用数: 0 h-index: 0机构: Seattle Canc Care Alliance, Seattle, WA USAWu, Haiyan论文数: 0 引用数: 0 h-index: 0机构: Seattle Canc Care Alliance, Seattle, WA USASchloss, Charles论文数: 0 引用数: 0 h-index: 0机构: Seattle Canc Care Alliance, Seattle, WA USA
- [2] KEYNOTE-365 cohort D: phase 1b/2 study of pembrolizumab plus abiraterone acetate and prednisone in metastatic castration-resistant prostate cancerJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7Appleman, Leonard论文数: 0 引用数: 0 h-index: 0机构: UPMC Hillman Canc Ctr, Pittsburgh, PA USA UPMC Hillman Canc Ctr, Pittsburgh, PA USAPiulats, Josep论文数: 0 引用数: 0 h-index: 0机构: Catalan Canc Inst, Barcelona, Spain UPMC Hillman Canc Ctr, Pittsburgh, PA USAMar, Nataliya论文数: 0 引用数: 0 h-index: 0机构: UC Irvine Med Ctr, Orange, CA USA UPMC Hillman Canc Ctr, Pittsburgh, PA USAArranz, Jose论文数: 0 引用数: 0 h-index: 0机构: Hosp Gen Univ Gregorio Maranon, Madrid, Spain UPMC Hillman Canc Ctr, Pittsburgh, PA USAJoshua, Anthony论文数: 0 引用数: 0 h-index: 0机构: St Vincents Hosp Sydney, Sydney, NSW, Australia UPMC Hillman Canc Ctr, Pittsburgh, PA USAMayer, Tina论文数: 0 引用数: 0 h-index: 0机构: Rutgers Canc Inst New Jersey, New Brunswick, NJ USA UPMC Hillman Canc Ctr, Pittsburgh, PA USAShore, Neal论文数: 0 引用数: 0 h-index: 0机构: Carolina Urol Res Ctr, Myrtle Beach, SC USA UPMC Hillman Canc Ctr, Pittsburgh, PA USAWu, Haiyan论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA UPMC Hillman Canc Ctr, Pittsburgh, PA USASchloss, Charles论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA UPMC Hillman Canc Ctr, Pittsburgh, PA USA论文数: 引用数: h-index:机构:
- [3] Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort B StudyEUROPEAN UROLOGY, 2022, 82 (01) : 22 - 30Yu, Evan Y.论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Dept Med, Div Oncol, 825 Eastlake Ave E,G4-830, Seattle, WA 98109 USA Fred Hutchinson Canc Res Ctr, 825 Eastlake Ave E,G4-830, Seattle, WA 98109 USA Univ Washington, Dept Med, Div Oncol, 825 Eastlake Ave E,G4-830, Seattle, WA 98109 USAKolinsky, Michael P.论文数: 0 引用数: 0 h-index: 0机构: Cross Canc Inst, Dept Oncol, Edmonton, AB, Canada Univ Washington, Dept Med, Div Oncol, 825 Eastlake Ave E,G4-830, Seattle, WA 98109 USABerry, William R.论文数: 0 引用数: 0 h-index: 0机构: Duke Canc Ctr Cary, Dept Med Oncol, Cary, NC USA Univ Washington, Dept Med, Div Oncol, 825 Eastlake Ave E,G4-830, Seattle, WA 98109 USARetz, Margitta论文数: 0 引用数: 0 h-index: 0机构: Tech Univ Munich, Rechts Isar Med Ctr, Dept Urol, Munich, Germany Univ Washington, Dept Med, Div Oncol, 825 Eastlake Ave E,G4-830, Seattle, WA 98109 USAMourey, Loic论文数: 0 引用数: 0 h-index: 0机构: Inst Univ Canc Toulouse Oncopole, Dept Med Oncol, Toulouse, France Univ Washington, Dept Med, Div Oncol, 825 Eastlake Ave E,G4-830, Seattle, WA 98109 USAPiulats, Josep M.论文数: 0 引用数: 0 h-index: 0机构: Catalan Inst Oncol, Dept Med Oncol, Barcelona, Spain Univ Washington, Dept Med, Div Oncol, 825 Eastlake Ave E,G4-830, Seattle, WA 98109 USAAppleman, Leonard J.论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Dept Med, Dept Hematol Oncol, Pittsburgh, PA USA Univ Washington, Dept Med, Div Oncol, 825 Eastlake Ave E,G4-830, Seattle, WA 98109 USARomano, Emanuela论文数: 0 引用数: 0 h-index: 0机构: Inst Curie, Ctr Canc Immunotherapy, Dept Med Oncol, Paris, France Univ Washington, Dept Med, Div Oncol, 825 Eastlake Ave E,G4-830, Seattle, WA 98109 USAGravis, Gwenaelle论文数: 0 引用数: 0 h-index: 0机构: Aix Marseille Univ, Inst Paoli Calmettes, Dept Med Oncol, Marseille, France Univ Washington, Dept Med, Div Oncol, 825 Eastlake Ave E,G4-830, Seattle, WA 98109 USA论文数: 引用数: h-index:机构:Bogemann, Martin论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Munster, Dept Urol, Munster, Germany Univ Washington, Dept Med, Div Oncol, 825 Eastlake Ave E,G4-830, Seattle, WA 98109 USAEmmenegger, Urban论文数: 0 引用数: 0 h-index: 0机构: Odette Canc Ctr, Div Med Oncol, Toronto, ON, Canada Sunnybrook Res Inst, Toronto, ON, Canada Univ Washington, Dept Med, Div Oncol, 825 Eastlake Ave E,G4-830, Seattle, WA 98109 USAJoshua, Anthony M.论文数: 0 引用数: 0 h-index: 0机构: St Vincents Hosp, Dept Med Oncol, Kinghorn Canc Ctr, Sydney, NSW, Australia Univ Washington, Dept Med, Div Oncol, 825 Eastlake Ave E,G4-830, Seattle, WA 98109 USALinch, Mark论文数: 0 引用数: 0 h-index: 0机构: Univ Coll London Hosp, Dept Oncol, London, England UCL Canc Inst, London, England Univ Washington, Dept Med, Div Oncol, 825 Eastlake Ave E,G4-830, Seattle, WA 98109 USASridhar, Srikala论文数: 0 引用数: 0 h-index: 0机构: UHN Princess Margaret Canc Ctr, Canc Clin Res Unit, Toronto, ON, Canada Univ Washington, Dept Med, Div Oncol, 825 Eastlake Ave E,G4-830, Seattle, WA 98109 USAConter, Henry J.论文数: 0 引用数: 0 h-index: 0机构: Univ Western Ontario, Dept Med Oncol, Brampton, ON, Canada Univ Washington, Dept Med, Div Oncol, 825 Eastlake Ave E,G4-830, Seattle, WA 98109 USALaguerre, Brigitte论文数: 0 引用数: 0 h-index: 0机构: Ctr Eugene Marquis, Dept Med Oncol, Rennes, France Univ Washington, Dept Med, Div Oncol, 825 Eastlake Ave E,G4-830, Seattle, WA 98109 USAMassard, Christophe论文数: 0 引用数: 0 h-index: 0机构: Gustave Roussy Canc Campus, Dept Drug Dev, Villejuif, France Univ Paris Sud, Villejuif, France Gustave Roussy Canc Campus, Dept Med Oncol, Villejuif, France Univ Washington, Dept Med, Div Oncol, 825 Eastlake Ave E,G4-830, Seattle, WA 98109 USALi, Xin Tong论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Dept Med Oncol, Kenilworth, NJ USA Univ Washington, Dept Med, Div Oncol, 825 Eastlake Ave E,G4-830, Seattle, WA 98109 USASchloss, Charles论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Dept Med Oncol, Kenilworth, NJ USA Univ Washington, Dept Med, Div Oncol, 825 Eastlake Ave E,G4-830, Seattle, WA 98109 USAPoehlein, Christian H.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Dept Med Oncol, Kenilworth, NJ USA Univ Washington, Dept Med, Div Oncol, 825 Eastlake Ave E,G4-830, Seattle, WA 98109 USAde Bono, Johann S.论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Div Clin Studies, London, England Inst Canc Res, London, England Univ Washington, Dept Med, Div Oncol, 825 Eastlake Ave E,G4-830, Seattle, WA 98109 USA
- [4] Pembrolizumab (pembro) plus olaparib in patients (pts) with docetaxel-pretreated metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 Cohort A updateANNALS OF ONCOLOGY, 2020, 31 : S513 - S514Arranz Arija, J. A.论文数: 0 引用数: 0 h-index: 0机构: Gen Univ Hosp Gregorio Maranon, Med Oncol, Madrid, Spain Gen Univ Hosp Gregorio Maranon, Med Oncol, Madrid, SpainYu, E. Y.论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Med Oncol Dept, Seattle, WA 98195 USA Gen Univ Hosp Gregorio Maranon, Med Oncol, Madrid, SpainPiulats, J. M.论文数: 0 引用数: 0 h-index: 0机构: Catalan Inst Oncol, Med Oncol, Barcelona, Spain Gen Univ Hosp Gregorio Maranon, Med Oncol, Madrid, SpainGravis, G.论文数: 0 引用数: 0 h-index: 0机构: Inst Paoli Calmettes, Med Oncol, Marseille, France Gen Univ Hosp Gregorio Maranon, Med Oncol, Madrid, SpainLaguerre, B.论文数: 0 引用数: 0 h-index: 0机构: Ctr Eugene Marquis, Med Oncol, Rennes, France Gen Univ Hosp Gregorio Maranon, Med Oncol, Madrid, SpainOudard, S.论文数: 0 引用数: 0 h-index: 0机构: Hop Europeen Georges Pompidou, Med Oncol, Paris, France Gen Univ Hosp Gregorio Maranon, Med Oncol, Madrid, SpainFong, P. C.论文数: 0 引用数: 0 h-index: 0机构: Auckland City Hosp, Med Oncol, Auckland, New Zealand Gen Univ Hosp Gregorio Maranon, Med Oncol, Madrid, SpainKolinsky, M. P.论文数: 0 引用数: 0 h-index: 0机构: Cross Canc Inst, Med Oncol, Edmonton, AB, Canada Gen Univ Hosp Gregorio Maranon, Med Oncol, Madrid, SpainAugustin, M.论文数: 0 引用数: 0 h-index: 0机构: Paracelsus Med Univ, Internal Med, Nurnberg, Germany Gen Univ Hosp Gregorio Maranon, Med Oncol, Madrid, SpainTodenhofer, T.论文数: 0 引用数: 0 h-index: 0机构: Gen Univ Hosp Gregorio Maranon, Med Oncol, Madrid, SpainKam, A. E.论文数: 0 引用数: 0 h-index: 0机构: Rush Univ, Med Ctr, Med Oncol, Chicago, IL 60612 USA Gen Univ Hosp Gregorio Maranon, Med Oncol, Madrid, SpainGurney, H.论文数: 0 引用数: 0 h-index: 0机构: Macquarie Univ Hosp, Clin Med, Sydney, NSW, Australia Gen Univ Hosp Gregorio Maranon, Med Oncol, Madrid, SpainTafreshi, A.论文数: 0 引用数: 0 h-index: 0机构: Univ Wollongong, Oncol, Wollongong, NSW, Australia Gen Univ Hosp Gregorio Maranon, Med Oncol, Madrid, SpainRetz, M.论文数: 0 引用数: 0 h-index: 0机构: Tech Univ Munich, Dept Urol, Univ Rechts Isar Hosp, Munich, Germany Gen Univ Hosp Gregorio Maranon, Med Oncol, Madrid, SpainBerry, W. R.论文数: 0 引用数: 0 h-index: 0机构: Duke Canc Ctr Cary, Med Oncol, Cary, NC USA Gen Univ Hosp Gregorio Maranon, Med Oncol, Madrid, SpainMar, N.论文数: 0 引用数: 0 h-index: 0机构: UCI Hlth, Hematol Oncol, Orange, CA USA Gen Univ Hosp Gregorio Maranon, Med Oncol, Madrid, SpainWu, H.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Med Oncol, Kenilworth, NJ USA Gen Univ Hosp Gregorio Maranon, Med Oncol, Madrid, SpainQiu, P.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Med Oncol, Kenilworth, NJ USA Gen Univ Hosp Gregorio Maranon, Med Oncol, Madrid, SpainSchloss, C.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Med Oncol, Kenilworth, NJ USA Gen Univ Hosp Gregorio Maranon, Med Oncol, Madrid, Spainde Bono, J. S.论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden NHS Fdn Trust, Med Oncol, London, England Gen Univ Hosp Gregorio Maranon, Med Oncol, Madrid, Spain
- [5] KEYNOTE-365 cohort A updated results: Pembrolizumab (pembro) plus olaparib in docetaxel-pretreated patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)Yu, Evan Y.论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USAPiulats, Josep M.论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USAGravis, Gwenaelle论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USALaguerre, Brigitte论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USAArija, Jose Angel Arranz论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USAOudard, Stephane论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USAFong, Peter C. C.论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USAKolinsky, Michael Paul论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USAAugustin, Marinela论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USAFeyerabend, Susan论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USAKam, Audrey E.论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USAGurney, Howard论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USATafreshi, Ali论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USARetz, Margitta论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USABerry, William R.论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USAMar, Nataliya论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USAWu, Helen论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USASchloss, Charles论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USAPoehlein, Christian Heinrich论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USADe Bono, Johann S.论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USA
- [6] Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A StudyEUROPEAN UROLOGY, 2023, 83 (01) : 15 - 26Yu, Evan Y.论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA USA Fred Hutchinson Canc Ctr, Seattle, WA USA Univ Washington, Seattle, WA USAPiulats, Josep M.论文数: 0 引用数: 0 h-index: 0机构: Catalan Inst Oncol, Barcelona, Spain Univ Washington, Seattle, WA USAGravis, Gwenaelle论文数: 0 引用数: 0 h-index: 0机构: Inst Paoli Calmettes, Marseille, France Univ Washington, Seattle, WA USAFong, Peter C. C.论文数: 0 引用数: 0 h-index: 0机构: Auckland City Hosp, Auckland, New Zealand Univ Auckland, Auckland, New Zealand Univ Washington, Seattle, WA USATodenhofer, Tilman论文数: 0 引用数: 0 h-index: 0机构: Studienpraxis Urol, Nurtingen, Germany Univ Washington, Seattle, WA USALaguerre, Brigitte论文数: 0 引用数: 0 h-index: 0机构: Ctr Eugene Marquis, Rennes, France Univ Washington, Seattle, WA USAArranz, Jose A.论文数: 0 引用数: 0 h-index: 0机构: Gen Univ Hosp Gregorio Maranon, Madrid, Spain Univ Washington, Seattle, WA USAOudard, Stephane论文数: 0 引用数: 0 h-index: 0机构: Univ Paris, Hop Europeen Georges Pompidou, Paris, France Univ Washington, Seattle, WA USA论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:Nordquist, Luke T.论文数: 0 引用数: 0 h-index: 0机构: GU Res Network, Urol Canc Ctr, Omaha, NE USA Univ Washington, Seattle, WA USACarles, Joan论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron, Vall dHebron Inst Oncol, Barcelona, Spain Univ Washington, Seattle, WA USAKolinsky, Michael P.论文数: 0 引用数: 0 h-index: 0机构: Cross Canc Inst, Edmonton, AB, Canada Univ Alberta, Edmonton, AB, Canada Univ Washington, Seattle, WA USAAugustin, Marinela论文数: 0 引用数: 0 h-index: 0机构: Paracelsus Med Univ, Nurnberg, Germany Univ Washington, Seattle, WA USA论文数: 引用数: h-index:机构:Tafreshi, Ali论文数: 0 引用数: 0 h-index: 0机构: Univ Wollongong, Wollongong, NSW, Australia Univ Washington, Seattle, WA USALi, Xin Tong论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Rahway, NJ USA Univ Washington, Seattle, WA USAQiu, Ping论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Rahway, NJ USA Univ Washington, Seattle, WA USAPoehlein, Christian H.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Rahway, NJ USA Univ Washington, Seattle, WA USASchloss, Charles论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Rahway, NJ USA Univ Washington, Seattle, WA USAde Bono, Johann S.论文数: 0 引用数: 0 h-index: 0机构: Inst Canc Res & Royal Marsden, London, England Univ Washington, Seattle, WA USA
- [7] Pembrolizumab (pembro) plus olaparib in docetaxel-pretreated patients (pts) with metastatic castrate resistant prostate cancer (mCRPC): Cohort A of the phase 1b/2 KEYNOTE-365 study.JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)Yu, Evan Y.论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USAMassard, Christophe论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USARetz, Margitta论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USATafreshi, Ali论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USACarles, Joan论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USAHammerer, Peter论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USAFong, Peter C. C.论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USAShore, Neal D.论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USAJoshua, Anthony M.论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USALinch, Mark David论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USAGurney, Howard论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USARomano, Emanuela论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USAAugustin, Marinela论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USAPiulats, Josep M.论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USAWu, Helen论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USASchloss, Charles论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USAPoehlein, Christian Heinrich论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USADe Bono, Johann S.论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USA
- [8] PEMBROLIZUMAB plus LENVATINIB IN PATIENTS WITH ADENOCARCINOMA METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) OR TREATMENT-EMERGENT NEUROENDOCRINE MCRPC: PHASE 1B/2 KEYNOTE-365 COHORTS E/FJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A449 - A449论文数: 引用数: h-index:机构:Shore, Neal论文数: 0 引用数: 0 h-index: 0机构: Carolina Urol Res Ctr, Myrtle Beach, SC USA Med Univ Vienna, Vienna, AustriaJoshua, Anthony论文数: 0 引用数: 0 h-index: 0机构: St Vincents Hosp Sydney, Sydney, NSW, Australia Med Univ Vienna, Vienna, AustriaLi, Xin Tong论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Med Univ Vienna, Vienna, AustriaPoehlein, Christian论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Med Univ Vienna, Vienna, AustriaSchloss, Charles论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Med Univ Vienna, Vienna, AustriaDe Bono, Johann论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden NHS Fdn Trust, London, England Med Univ Vienna, Vienna, Austria论文数: 引用数: h-index:机构:
- [9] PEMBROLIZUMAB plus VIBOSTOLIMAB IN PATIENTS WITH ADENOCARCINOMA METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) OR TREATMENT-EMERGENT NEUROENDOCRINE MCRPC: PHASE 1B/2 KEYNOTE-365 COHORTS G/HJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A455 - A455Shore, Neal论文数: 0 引用数: 0 h-index: 0机构: Carolina Urol Res Ctr, Myrtle Beach, SC USA Carolina Urol Res Ctr, Myrtle Beach, SC USADe Bono, Johann论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden NHS Fdn Trust, London, England Carolina Urol Res Ctr, Myrtle Beach, SC USA论文数: 引用数: h-index:机构:Joshua, Anthony论文数: 0 引用数: 0 h-index: 0机构: St Vincents Hosp Sydney, Sydney, NSW, Australia Carolina Urol Res Ctr, Myrtle Beach, SC USALi, Xin Tong论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Carolina Urol Res Ctr, Myrtle Beach, SC USAPoehlein, Christian论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Carolina Urol Res Ctr, Myrtle Beach, SC USASchloss, Charles论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Carolina Urol Res Ctr, Myrtle Beach, SC USA论文数: 引用数: h-index:机构:
- [10] Pembrolizumab Combination Therapies in Patients With Metastatic Castration-Resistant Prostate Cancer: Cohorts A-C of the Phase 1b/2 KEYNOTE-365 StudyASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 : 46 - 47Joshua, Anthony M.论文数: 0 引用数: 0 h-index: 0Gurney, Howard论文数: 0 引用数: 0 h-index: 0Retz, Margitta论文数: 0 引用数: 0 h-index: 0Tafreshi, Ali论文数: 0 引用数: 0 h-index: 0Fong, Peter论文数: 0 引用数: 0 h-index: 0Shore, Neal论文数: 0 引用数: 0 h-index: 0Romano, Emanuela论文数: 0 引用数: 0 h-index: 0Augustin, Marinela论文数: 0 引用数: 0 h-index: 0Piulats, Josep M.论文数: 0 引用数: 0 h-index: 0Berry, William R.论文数: 0 引用数: 0 h-index: 0Kolinsky, Michael Paul论文数: 0 引用数: 0 h-index: 0Sridhar, Srikala S.论文数: 0 引用数: 0 h-index: 0Conter, Henry Joacob论文数: 0 引用数: 0 h-index: 0Todenhofer, Tilman论文数: 0 引用数: 0 h-index: 0Appleman, Leonard J.论文数: 0 引用数: 0 h-index: 0Wu, Haiyan论文数: 0 引用数: 0 h-index: 0Schloss, Charles论文数: 0 引用数: 0 h-index: 0Poehlein, Christian Heinrich论文数: 0 引用数: 0 h-index: 0de Bono, Johann S.论文数: 0 引用数: 0 h-index: 0Yu, Evan Y.论文数: 0 引用数: 0 h-index: 0